ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 133 filers reported holding ARRAY BIOPHARMA INC in Q3 2013. The put-call ratio across all filers is 16.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $550,000 | -90.4% | 120,612 | -84.8% | 0.05% | -90.5% |
| Q2 2015 | $5,714,000 | +28.7% | 792,571 | +31.6% | 0.56% | +28.3% |
| Q1 2015 | $4,440,000 | +3569.4% | 602,451 | +2165.6% | 0.44% | +4250.0% |
| Q2 2014 | $121,000 | -92.4% | 26,591 | -91.7% | 0.01% | -86.7% |
| Q4 2013 | $1,600,000 | -63.9% | 319,430 | -55.2% | 0.08% | -62.9% |
| Q3 2013 | $4,432,000 | +30.1% | 712,491 | -5.0% | 0.20% | +41.3% |
| Q2 2013 | $3,407,000 | – | 750,360 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 15,978,580 | $268,121,000 | 9.11% |
| BVF INC/IL | 4,672,195 | $78,399,000 | 7.65% |
| First Light Asset Management, LLC | 2,391,575 | $40,131,000 | 6.25% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 694,500 | $11,647,000 | 4.47% |
| Copernicus Capital Management, LLC | 286,797 | $4,812,000 | 3.49% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 225,511 | $3,784,000 | 3.00% |
| SECTORAL ASSET MANAGEMENT INC | 1,566,477 | $26,285,000 | 2.94% |
| X-Square Capital, LLC | 173,802 | $2,917,000 | 2.18% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2,618,654 | $43,941,000 | 1.48% |
| Birchview Capital, LP | 128,000 | $2,148,000 | 1.46% |